FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529430742> ?p ?o ?g. }

• W2529430742 endingPage "484" @default.
• W2529430742 startingPage "476" @default.
• W2529430742 abstract "Cancer and its treatment lead to increased financial distress for patients. To the authors' knowledge, to date, no standardized patient-reported outcome measure has been validated to assess this distress.Patients with AJCC Stage IV solid tumors receiving chemotherapy for at least 2 months were recruited. Financial toxicity was measured by the COmprehensive Score for financial Toxicity (COST) measure. The authors collected data regarding patient characteristics, clinical trial participation, health care use, willingness to discuss costs, psychological distress (Brief Profile of Mood States [POMS]), and health-related quality of life (HRQOL) as measured by the Functional Assessment of Cancer Therapy: General (FACT-G) and the European Organization for Research and Treatment of Cancer (EORTC) QOL questionnaires. Test-retest reliability, internal consistency, and validity of the COST measure were assessed using standard-scale construction techniques. Associations between the resulting factors and other variables were assessed using multivariable analyses.A total of 375 patients with advanced cancer were approached, 233 of whom (62.1%) agreed to participate. The COST measure demonstrated high internal consistency and test-retest reliability. Factor analyses revealed a coherent, single, latent variable (financial toxicity). COST values were found to be correlated with income (correlation coefficient [r] = 0.28; P<.001), psychosocial distress (r = -0.26; P<.001), and HRQOL, as measured by the FACT-G (r = 0.42; P<.001) and by the EORTC QOL instruments (r = 0.33; P<.001). Independent factors found to be associated with financial toxicity were race (P = .04), employment status (P<.001), income (P = .003), number of inpatient admissions (P = .01), and psychological distress (P = .003). Willingness to discuss costs was not found to be associated with the degree of financial distress (P = .49).The COST measure demonstrated reliability and validity in measuring financial toxicity. Its correlation with HRQOL indicates that financial toxicity is a clinically relevant patient-centered outcome. Cancer 2017;123:476-484. © 2016 American Cancer Society." @default.
• W2529430742 created "2016-10-14" @default.
• W2529430742 creator A5013560330 @default.
• W2529430742 creator A5025048434 @default.
• W2529430742 creator A5026315103 @default.
• W2529430742 creator A5027121307 @default.
• W2529430742 creator A5039180386 @default.
• W2529430742 creator A5040093544 @default.
• W2529430742 creator A5051856622 @default.
• W2529430742 creator A5058673346 @default.
• W2529430742 creator A5066535571 @default.
• W2529430742 creator A5068268371 @default.
• W2529430742 creator A5075918212 @default.
• W2529430742 creator A5086581232 @default.
• W2529430742 date "2016-10-07" @default.
• W2529430742 modified "2023-10-14" @default.
• W2529430742 title "Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)" @default.
• W2529430742 cites W1598788265 @default.
• W2529430742 cites W2096552494 @default.
• W2529430742 cites W2099354636 @default.
• W2529430742 cites W2100348247 @default.
• W2529430742 cites W2100860747 @default.
• W2529430742 cites W2105258029 @default.
• W2529430742 cites W2109334536 @default.
• W2529430742 cites W2115724268 @default.
• W2529430742 cites W2120996730 @default.
• W2529430742 cites W2128536774 @default.
• W2529430742 cites W2129542001 @default.
• W2529430742 cites W2134506226 @default.
• W2529430742 cites W2145012839 @default.
• W2529430742 cites W2148590504 @default.
• W2529430742 cites W2154835844 @default.
• W2529430742 cites W2157427387 @default.
• W2529430742 cites W2158919887 @default.
• W2529430742 cites W2167571044 @default.
• W2529430742 cites W2266198524 @default.
• W2529430742 cites W2292373964 @default.
• W2529430742 cites W4250968058 @default.
• W2529430742 doi "https://doi.org/10.1002/cncr.30369" @default.
• W2529430742 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5298039" @default.
• W2529430742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27716900" @default.
• W2529430742 hasPublicationYear "2016" @default.
• W2529430742 type Work @default.
• W2529430742 sameAs 2529430742 @default.
• W2529430742 citedByCount "458" @default.
• W2529430742 countsByYear W25294307422016 @default.
• W2529430742 countsByYear W25294307422017 @default.
• W2529430742 countsByYear W25294307422018 @default.
• W2529430742 countsByYear W25294307422019 @default.
• W2529430742 countsByYear W25294307422020 @default.
• W2529430742 countsByYear W25294307422021 @default.
• W2529430742 countsByYear W25294307422022 @default.
• W2529430742 countsByYear W25294307422023 @default.
• W2529430742 crossrefType "journal-article" @default.
• W2529430742 hasAuthorship W2529430742A5013560330 @default.
• W2529430742 hasAuthorship W2529430742A5025048434 @default.
• W2529430742 hasAuthorship W2529430742A5026315103 @default.
• W2529430742 hasAuthorship W2529430742A5027121307 @default.
• W2529430742 hasAuthorship W2529430742A5039180386 @default.
• W2529430742 hasAuthorship W2529430742A5040093544 @default.
• W2529430742 hasAuthorship W2529430742A5051856622 @default.
• W2529430742 hasAuthorship W2529430742A5058673346 @default.
• W2529430742 hasAuthorship W2529430742A5066535571 @default.
• W2529430742 hasAuthorship W2529430742A5068268371 @default.
• W2529430742 hasAuthorship W2529430742A5075918212 @default.
• W2529430742 hasAuthorship W2529430742A5086581232 @default.
• W2529430742 hasBestOaLocation W25294307421 @default.
• W2529430742 hasConcept C118552586 @default.
• W2529430742 hasConcept C121608353 @default.
• W2529430742 hasConcept C126322002 @default.
• W2529430742 hasConcept C139265228 @default.
• W2529430742 hasConcept C143998085 @default.
• W2529430742 hasConcept C150966472 @default.
• W2529430742 hasConcept C159110408 @default.
• W2529430742 hasConcept C1862650 @default.
• W2529430742 hasConcept C2779951463 @default.
• W2529430742 hasConcept C535046627 @default.
• W2529430742 hasConcept C70410870 @default.
• W2529430742 hasConcept C71924100 @default.
• W2529430742 hasConceptScore W2529430742C118552586 @default.
• W2529430742 hasConceptScore W2529430742C121608353 @default.
• W2529430742 hasConceptScore W2529430742C126322002 @default.
• W2529430742 hasConceptScore W2529430742C139265228 @default.
• W2529430742 hasConceptScore W2529430742C143998085 @default.
• W2529430742 hasConceptScore W2529430742C150966472 @default.
• W2529430742 hasConceptScore W2529430742C159110408 @default.
• W2529430742 hasConceptScore W2529430742C1862650 @default.
• W2529430742 hasConceptScore W2529430742C2779951463 @default.
• W2529430742 hasConceptScore W2529430742C535046627 @default.
• W2529430742 hasConceptScore W2529430742C70410870 @default.
• W2529430742 hasConceptScore W2529430742C71924100 @default.
• W2529430742 hasIssue "3" @default.
• W2529430742 hasLocation W25294307421 @default.
• W2529430742 hasLocation W25294307422 @default.
• W2529430742 hasLocation W25294307423 @default.
• W2529430742 hasLocation W25294307424 @default.
• W2529430742 hasOpenAccess W2529430742 @default.
• W2529430742 hasPrimaryLocation W25294307421 @default.

• next